Replimune Group, Inc. (REPL)
NASDAQ: REPL · Real-Time Price · USD
9.78
-0.11 (-1.11%)
At close: Jun 13, 2025, 4:00 PM
10.09
+0.31 (3.14%)
After-hours: Jun 13, 2025, 7:38 PM EDT
Replimune Group Employees
Replimune Group had 479 employees as of March 31, 2025. The number of employees increased by 148 or 44.71% compared to the previous year.
Employees
479
Change (1Y)
148
Growth (1Y)
44.71%
Revenue / Employee
n/a
Profits / Employee
-$516,278
Market Cap
753.91M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
REPL News
- 8 days ago - Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 13 days ago - Replimune Presents New Analyses from the IGNYTE Study of RP1 plus Nivolumab in Anti-PD1 Failed Melanoma at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting - GlobeNewsWire
- 16 days ago - Replimune to Present at the 2025 Jefferies Global Healthcare Conference - GlobeNewsWire
- 23 days ago - Replimune Group, Inc. (REPL) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 23 days ago - Replimune Reports Fiscal Fourth Quarter and Year End 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 4 weeks ago - Replimune Announces Dates for Fiscal Fourth Quarter and Year End 2025 Financial Results and Upcoming Investor Day - GlobeNewsWire
- 5 weeks ago - Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 weeks ago - Sibylla Biotech Appoints Former Bayer CEO, Dieter Weinand, as Chairman of the Board of Directors - GlobeNewsWire